The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke
Abstract
Background and Purpose Better techniques are needed to monitor infarction volume and predict neurological outcome after ischemic brain infarction. We evaluated the usefulness of serial measurements of S-100 protein versus neuron-specific enolase (NSE) in blood samples from patients with acute stroke. Methods Using nonisotopic sandwich immunoassays, we measured plasma concentrations of S-100 protein and NSE on admission and on days 3, 4, 7, and 14 after infarction in 44 patients (age range, 22 to 86 years; mean age, 65.1 years; 12 female, 32 male). Infarct volume was measured by volumetric CT on day 4 after ictus, and clinical outcome was assessed at discharge from hospital with the Activities of Daily Living Scale and 6 months after infarction with the Glasgow Outcome Scale. Results Peak blood levels of S-100 protein were found on day 2.5±1.3, and peak levels of NSE were found on day 1.9±0.8 after infarction. Peak plasma levels of S-100 protein correlated well with infarct volume ( r =.75, P <.001) and with clinical outcome assessed with the Glasgow Outcome Scale ( r =.51, P <.001). Serum levels of NSE correlated with infarct volume ( r =.37, P <.05) but not with clinical outcome ( r =.18, P >.05). Conclusions The results of our study indicate that measuring blood concentrations of S-100 protein periodically in the first 10 days after cerebral infarction helps to predict infarct volume and the long-term neurological outcome more accurately than periodic measurements of blood concentrations of NSE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Persson, L., Hårdemark, H. G., Gustafsson, J., Rundström, G., Mendel-Hartvig, I., Esscher, T., & Påhlman, S. (1987) · Stroke · doi:10.1161/01.str.18.5.911 · Cited by 486
Neuron Specific Enolase, A Clinically Useful Marker for Neurons and Neuroendocrine Cells
Marangos, P. J., & Schmechel, D. E. (1987) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.10.030187.001413 · Cited by 420
Perspectives in S-100 protein biology
Donato, R. (1991) · Cell Calcium · doi:10.1016/0143-4160(91)90040-l · Cited by 277
The S-100: A protein family in search of a function
Fanò, G., Biocca, S., Fulle, S., Mariggiò, M. A., Belia, S., & Calissano, P. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(94)00062-m · Cited by 212
Aurell, A., Rosengren, L. E., Karlsson, B., Olsson, J. E., Zbornikova, V, & Haglid, K. G. (1991) · Stroke · doi:10.1161/01.str.22.10.1254 · Cited by 210
Kim, J. S., Yoon, S. S., Kim, Y. H., & Ryu, J. S. (1996) · Stroke · doi:10.1161/01.str.27.9.1553 · Cited by 197
Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia
Barone, F. C., Clark, R. K., Price, W. J., White, R. F., Feuerstein, G., Storer, B. L., & Ohlstein, E. H. (1993) · Brain Research · doi:10.1016/0006-8993(93)90012-c · Cited by 115
Noppe, M., Crols, R., Andries, D., & Löwenthal, A. (1986) · Clinica Chimica Acta · doi:10.1016/0009-8981(86)90275-5 · Cited by 96
Butterworth, R. J., Wassif, W., Sherwood, R. A., Gerges, A., Poyser, K., Garthwaite, J., Peters, T. J., & Bath, P. M. (1996) · Stroke · doi:10.1161/01.str.27.11.2064 · Cited by 67
Cited by
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
S100 proteins structure functions and pathology
Heizmann, C. W. (2002) · Frontiers in Bioscience · doi:10.2741/a846 · Cited by 706
S100B in brain damage and neurodegeneration
Rothermundt, M., Peters, M., Prehn, J. H. M., & Arolt, V. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10303 · Cited by 609
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects
Isgrò, M. A., Bottoni, P., & Scatena, R. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-7215-0_9 · Cited by 575
Dayon, L., Hainard, A., Licker, V., Turck, N., Kuhn, K., Hochstrasser, D. F., Burkhard, P. R., & Sanchez, J.-C. (2008) · Analytical Chemistry · doi:10.1021/ac702422x · Cited by 561
Wijdicks, E. F. M., Sheth, K. N., Carter, B. S., Greer, D. M., Kasner, S. E., Kimberly, W. T., Schwab, S., Smith, E. E., Tamargo, R. J., & Wintermark, M. (2014) · Stroke · doi:10.1161/01.str.0000441965.15164.d6 · Cited by 522
Neurobehavioural sequelae of cardiopulmonary b ypass
Selnes, O. A., Goldsborough, M. A., Borowicz, L. M., & McKhann, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07576-x · Cited by 502
S100 proteins: structure, functions and pathology
Heizmann, C. (2002) · Frontiers in Bioscience · doi:10.2741/heizmann · Cited by 413
Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury
Vos, P. E., Lamers, K. J. B., Hendriks, J. C. M., van Haaren, M., Beems, T., Zimmerman, C., van Geel, W., de Reus, H., Biert, J., & Verbeek, M. M. (2004) · Neurology · doi:10.1212/01.wnl.0000120550.00643.dc · Cited by 412
Herrmann, M., Vos, P., Wunderlich, M. T., de Bruijn, C. H. M. M., & Lamers, K. J. B. (2000) · Stroke · doi:10.1161/01.str.31.11.2670 · Cited by 400
GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and Outcome
Pelinka, L. E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A., & Redl, H. R. (2004) · Journal of Neurotrauma · doi:10.1089/0897715042441846 · Cited by 389
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
De Keyser, J., Sulter, G., & Luiten, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01463-0 · Cited by 374
Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With Hypothermia
Tiainen, M., Roine, R. O., Pettilä, V., & Takkunen, O. (2003) · Stroke · doi:10.1161/01.str.0000103320.90706.35 · Cited by 318
Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury*
Papa, L., Akinyi, L., Liu, M. C., Pineda, J. A., Tepas, J. J., Oli, M. W., Zheng, W., Robinson, G., Robicsek, S. A., Gabrielli, A., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b788ab · Cited by 308
Thalamic and Subthalamic Deep Brain Stimulation for Essential Tremor: Where Is the Optimal Target?
Sandvik, U., Koskinen, L.-O., Lundquist, A., & Blomstedt, P. (2012) · Neurosurgery · doi:10.1227/neu.0b013e318236a809 · Cited by 292
Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
Whiteley, W., Chong, W. L., Sengupta, A., & Sandercock, P. (2009) · Stroke · doi:10.1161/strokeaha.108.528752 · Cited by 290
Serum S100β: A noninvasive marker of blood‐brain barrier function and brain lesions
Kanner, A. A., Marchi, N., Fazio, V., Mayberg, M. R., Koltz, M. T., Siomin, V., Stevens, G. H. J., Masaryk, T., Ayumar, B., Vogelbaum, M. A., et al. (2003) · Cancer · doi:10.1002/cncr.11409 · Cited by 269
Gonçalves, C.-A., Concli Leite, M., & Nardin, P. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.04.003 · Cited by 255
Lamers, K. J. B., Vos, P., Verbeek, M. M., Rosmalen, F., van Geel, W. J. A., & van Engelen, B. G. M. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00089-3 · Cited by 138
Metadata
- Authors
- Missler, U., Wiesmann, M., Friedrich, C., & Kaps, M.
- Venue
- Stroke
- Published
- 1997-10
- Volume
- 28
- Issue
- 10
- Pages
- 1956-1960
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1973390472
- Cited by
- 456
- References
- 12
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.